A critical advance in cancer research is occurring with the use of nanobodies to reactivate mutated p53. This essential cancer inhibitor protein is frequently disabled in various types of tumors, causing uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research